- Home
- RDY vs KEP Comparison
RDY vs KEP Comparison
Compare RDY & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- KEP
- Stock Information
- Founded
- RDY 1984
- KEP 1961
- Country
- RDY India
- KEP South Korea
- Employees
- RDY N/A
- KEP N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- KEP Electric Utilities: Central
- Sector
- RDY Health Care
- KEP Utilities
- Exchange
- RDY Nasdaq
- KEP Nasdaq
- Market Cap
- RDY 11.9B
- KEP 9.9B
- IPO Year
- RDY N/A
- KEP N/A
- Fundamental
- Price
- RDY $15.38
- KEP $7.14
- Analyst Decision
- RDY Buy
- KEP
- Analyst Count
- RDY 1
- KEP 0
- Target Price
- RDY $17.00
- KEP N/A
- AVG Volume (30 Days)
- RDY 1.6M
- KEP 297.7K
- Earning Date
- RDY 01-28-2025
- KEP 12-31-2024
- Dividend Yield
- RDY 3.74%
- KEP N/A
- EPS Growth
- RDY 4.63
- KEP N/A
- EPS
- RDY 0.76
- KEP 4.40
- Revenue
- RDY $3,579,112,656.00
- KEP $70,353,349,144.00
- Revenue This Year
- RDY $13.39
- KEP $5.44
- Revenue Next Year
- RDY $8.35
- KEP $3.10
- P/E Ratio
- RDY $20.68
- KEP $3.19
- Revenue Growth
- RDY 12.37
- KEP 8.48
- 52 Week Low
- RDY $13.41
- KEP $6.69
- 52 Week High
- RDY $16.89
- KEP $9.55
- Technical
- Relative Strength Index (RSI)
- RDY 66.14
- KEP 33.30
- Support Level
- RDY $14.45
- KEP $7.31
- Resistance Level
- RDY $14.85
- KEP $7.57
- Average True Range (ATR)
- RDY 0.19
- KEP 0.14
- MACD
- RDY 0.13
- KEP -0.08
- Stochastic Oscillator
- RDY 88.17
- KEP 8.39
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.